<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<REGINFO_RIN_DATA xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" RUN_DATE="2026-04-28-04:00" xsi:noNamespaceSchemaLocation="https://www.reginfo.gov/public/xml/REGINFO_XML_Ver10262011.xsd">
    <RIN_INFO>
        <RIN>3041-AC43</RIN>
        <PUBLICATION>
            <PUBLICATION_ID>200904</PUBLICATION_ID>
            <PUBLICATION_TITLE>Unified Agenda of Federal Regulatory and Deregulatory Actions</PUBLICATION_TITLE>
        </PUBLICATION>
        <AGENCY>
            <CODE>3041</CODE>
            <NAME>Consumer Product Safety Commission</NAME>
            <ACRONYM>CPSC</ACRONYM>
        </AGENCY>
        <RULE_TITLE>Inaccessible Component Parts in Children&apos;s Products Containing Lead</RULE_TITLE>
        <ABSTRACT><![CDATA[Section 101(b)(2)(B) of the Consumer Product Safety Improvement Act of 2008 (CPSIA), Public Law 110-314, 122 Stat. 3016 (August 14, 2008), requires the Commission to promulgate a rule providing guidance with respect to what components, or classes of components, of children's products will be considered to be inaccessible.  The CPSIA directs the Commission to promulgate the rule by August 14, 2009. On January 15, 2009, the Commission published a notice of proposed interpretative rule providing guidance on with respect to what product components or classes of components will be considered to be inaccessible under section 101(b) of the Consumer Product Safety Improvement Act of 2008 (CPSIA), Public Law 110-314. The proposed interpretative rule stated that a lead-containing component part would be evaluated on the accessibility of lead-containing component parts of a childrens product as a result of normal and reasonably foreseeable use and abuse of the product by children based on: accessibility probes specified for sharp points or edges under the Commissions regulations at 16 CFR 1500.48-1500.49; and the use and abuse tests set forth under the Commissions regulations at 16 CFR 1500.50-1500.53 (excluding the bite tests of 1500.51(c) and 1500.52(c)) Children's Products Containing Lead: Exemption for Certain Electronic Devices; Notice of Proposed Rulemaking. The notice solicited comments on proposed interpretative rule by February 17, 2008. The Commission staff will review public comments on the proposed rule and prepare a briefing package for Commission consideration.]]></ABSTRACT>
        <PRIORITY_CATEGORY>Substantive, Nonsignificant</PRIORITY_CATEGORY>
        <RIN_STATUS>Previously Published in The Unified Agenda</RIN_STATUS>
        <RULE_STAGE>Final Rule Stage</RULE_STAGE>
        <MAJOR>Undetermined</MAJOR>
        <UNFUNDED_MANDATE_LIST>
            <UNFUNDED_MANDATE>No</UNFUNDED_MANDATE>
        </UNFUNDED_MANDATE_LIST>
        <CFR_LIST>
            <CFR>16 CFR 1500</CFR>
        </CFR_LIST>
        <LEGAL_AUTHORITY_LIST>
            <LEGAL_AUTHORITY>PL 110-314, sec 101(b)(2)(B)</LEGAL_AUTHORITY>
        </LEGAL_AUTHORITY_LIST>
        <LEGAL_DLINE_LIST>
            <LEGAL_DLINE_INFO>
                <DLINE_TYPE>Statutory</DLINE_TYPE>
                <DLINE_ACTION_STAGE>Final</DLINE_ACTION_STAGE>
                <DLINE_DATE>08/14/2009</DLINE_DATE>
                <DLINE_DESC> </DLINE_DESC>
            </LEGAL_DLINE_INFO>
        </LEGAL_DLINE_LIST>
        <RPLAN_ENTRY>No</RPLAN_ENTRY>
        <TIMETABLE_LIST>
            <TIMETABLE>
                <TTBL_ACTION>Staff Sent Briefing Package to Commission </TTBL_ACTION>
                <TTBL_DATE>12/23/2008</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Commission Decision on Federal Register Notice for Draft NPRM</TTBL_ACTION>
                <TTBL_DATE>01/05/2009</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>NPRM Published in Federal Register</TTBL_ACTION>
                <TTBL_DATE>01/15/2009</TTBL_DATE>
                <FR_CITATION>74 FR 2439</FR_CITATION>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>NPRM Comment Period End</TTBL_ACTION>
                <TTBL_DATE>02/17/2009</TTBL_DATE>
            </TIMETABLE>
            <TIMETABLE>
                <TTBL_ACTION>Briefing Package to Commission</TTBL_ACTION>
                <TTBL_DATE>05/00/2009</TTBL_DATE>
            </TIMETABLE>
        </TIMETABLE_LIST>
        <RFA_REQUIRED>Undetermined</RFA_REQUIRED>
        <GOVT_LEVEL_LIST>
            <GOVT_LEVEL>None</GOVT_LEVEL>
        </GOVT_LEVEL_LIST>
        <FEDERALISM>No</FEDERALISM>
        <ENERGY_AFFECTED>No</ENERGY_AFFECTED>
        <PRINT_PAPER>No</PRINT_PAPER>
        <INTERNATIONAL_INTEREST>Yes</INTERNATIONAL_INTEREST>
        <AGENCY_CONTACT_LIST>
            <CONTACT>
                <FIRST_NAME>Kristina</FIRST_NAME>
                <LAST_NAME>Hatlelid</LAST_NAME>
                <MIDDLE_NAME>M.</MIDDLE_NAME>
                <SUFFIX>Ph.D.</SUFFIX>
                <TITLE>Project Manager</TITLE>
                <AGENCY>
                    <CODE>3041</CODE>
                </AGENCY>
                <PHONE>301 987-2558</PHONE>
                <EMAIL>khatlelid@cpsc.gov</EMAIL>
                <MAILING_ADDRESS>
                    <STREET_ADDRESS>Directorate for Health Sciences, 5 Research Place,</STREET_ADDRESS>
                    <CITY>Rockville</CITY>
                    <STATE>MD</STATE>
                    <ZIP>20850</ZIP>
                </MAILING_ADDRESS>
            </CONTACT>
        </AGENCY_CONTACT_LIST>
    </RIN_INFO>
</REGINFO_RIN_DATA>
